Mucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...

New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...

AbbVie claims that Genmab divulged key trade secrets to support the development of ProfoundBio’s investigational ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Oxford BioTherapeutics (OBT) has entered a multi-year partnership with Roche to discover antibody-based therapeutics for ...

New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments ...

Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for ...

Byondis B.V., an independent clinical stage biopharmaceutical company creating innovative targeted medicines for patients ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.